Oral treatment for KS.
D000284:Administration, Oral; D000287:Administration, Topical; D017277:Drug Approval; D006801:Humans; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D014212:Tretinoin / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D014212:Tretinoin